Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Food Allergies
Main Article Content
Keywords
Atopic Dermatitis, Crisaborole, Food Allergies
Abstract
Abstract not available.
References
1. Dharmage SC et al. Curr Opin Allergy Clin Immunol. 2004;4(5):379-385.
2. Werfel T, Breuer K. Curr Opin Allergy Clin Immunol. 2004;4(5):379-385.
3. Robison RG, Singh AM. J Allergy Clin Immunol Pract. 2019;7(1):35-39.
4. Eucrisa (crisaborole) ointment, 2%, for topical use [package insert]. New York, NY: Pfizer Labs; April 2020.
5. Paller AS et al. J Am Acad Dermatol. 2016;75(3):494-503.e496.
6. Hanifin JM, Rajka G. Acta Derm Venereol. 1980;60(92):44-47.
7. Yosipovitch G et al. Itch. 2018;3:e13.
2. Werfel T, Breuer K. Curr Opin Allergy Clin Immunol. 2004;4(5):379-385.
3. Robison RG, Singh AM. J Allergy Clin Immunol Pract. 2019;7(1):35-39.
4. Eucrisa (crisaborole) ointment, 2%, for topical use [package insert]. New York, NY: Pfizer Labs; April 2020.
5. Paller AS et al. J Am Acad Dermatol. 2016;75(3):494-503.e496.
6. Hanifin JM, Rajka G. Acta Derm Venereol. 1980;60(92):44-47.
7. Yosipovitch G et al. Itch. 2018;3:e13.